Frankfurt - Delayed Quote EUR
UCB SA (UNC.F)
163.15
+2.30
+(1.43%)
As of 8:07:54 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 14 | 14 |
| Avg. Estimate | -- | -- | 6.75B | 7.66B |
| Low Estimate | -- | -- | 6.55B | 6.96B |
| High Estimate | -- | -- | 7.03B | 8.1B |
| Year Ago Sales | -- | -- | 6.15B | 6.75B |
| Sales Growth (year/est) | -- | -- | 9.78% | 13.38% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| UNC.F | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.38% | 7.54% | 14.08% |
Related Tickers
2BO.F Serina Therapeutics Inc. R
5.05
+1.00%
BT3.BE Lineage Cell Therapeutics Inc
0.7250
+23.93%
300381.SZ Guangdong VTR Bio-Tech Co., Ltd.
7.72
+0.26%
5KW.F SkinBioTherapeutics plc
0.1840
0.00%
GXE.F Galapagos NV
24.86
+0.40%
8QQ.BE AbCellera Biologics Inc
2.7660
+7.21%
GENSY Genus plc
24.34
0.00%
ITRX inTerra Resources Corp
0.0381
+58.75%
AB3A.MU Sarepta Therapeutics Inc
16.91
-46.87%
ONCIN.OL Oncoinvent ASA
1.9840
+7.24%